Format

Send to

Choose Destination
See comment in PubMed Commons below
J Otolaryngol Head Neck Surg. 2012 Feb;41(1):41-5.

Medialization thyroplasty for unilateral vocal cord paralysis secondary to advanced extralaryngeal malignant disease: review of operative morbidity and patient life expectancy.

Author information

  • 1Division of Otolaryngology-Head and Neck Surgery, University of Alberta, Edmonton, AB.

Abstract

OBJECTIVE:

To review the operative morbidity and the overall length of survival following medialization thyroplasty for unilateral vocal cord paralysis (UVCP) due to advanced extralaryngeal malignancy.

DESIGN:

Retrospective review.

SETTING:

Tertiary care laryngology practice.

METHOD:

All cases of medialization thyroplasty over a 3-year period were reviewed. Only patients who had UVCP due to advanced extralaryngeal malignancy were included. Any cases from iatrogenic causes or for any other reason were excluded. Survival days were calculated from the date of the thyroplasty.

MAIN OUTCOME MEASURE:

Survival days postmedialization thyroplasty.

RESULTS:

Twenty-one patients met the inclusion criteria. Two distinct groups within this cohort were identified: (1) those suffering from advanced lung cancer and (2) those with metastatic cancer of another origin (ie, breast, renal cell, esophageal). There were 11 patients in the lung cancer group and 10 in the other group. Average survival was 538 days in the lung cancer group and 668 days in the other group. The procedure was well tolerated, with only one postoperative complication, which was a minor wound infection.

CONCLUSION:

For patients suffering from advanced malignancy, medialization thyroplasty is a safe procedure and an excellent modality for voice palliation.

PMID:
22498267
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center